These mutations interfere with the intrinsic GTPase activity of Gsα in FD-derived bone marrow stromal cells (BMSCs), resulting in continuous constitutive receptor activation and the triggering of inappropriate cAMP/PKA/CREB signaling pathway transduction [4,5]. This evidence concerns the gene GNAS and Fabry disease.